Evidence map›Paper›PMID 41354764›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting

Jan Wuestemann, Elisabeth Eppard, Daniel Hescheler, Joanna Wybranska, Dennis Kupitz, Falco Reissig, Frankis G Almaguel, Akram Al-Ibraheem, Johannes Notni, Michael C Kreissl

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Adsorption treatment ofAnnals of nuclear medicine · 2026
    Article
  3. First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin.European journal of nuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jan WuestemannDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Germany.
Elisabeth EppardDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Germany.
Daniel HeschelerDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Germany.
Joanna WybranskaDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Germany.
Dennis KupitzDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Germany.
Falco ReissigTRIMT GmbH, Carl-Eschebach-Str. 7, 01454, Radeberg, Germany.
Frankis G AlmaguelDepartment of Radiology, Wake Forest School of Medicine, Winston Salem, NC, USA.
Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
Johannes NotniTRIMT GmbH, Carl-Eschebach-Str. 7, 01454, Radeberg, Germany. tum@notni.de.ORCID http://orcid.org/0000-0002-3964-3391
Michael C KreisslDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41354764
PMCPMC13197237

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.